← Leaderboards
Sushanta K Banerjee
Kansas City Va Medical Center
$510,300
Attributed
$510,300
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $0 · FY2013–25$1$1$1$0$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$510,300 · 1
VA$0 · 4
By mechanism
R01$510,300 · 1
I01$0 · 3
IK6$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelProteinsTumor GrowthGrowthNeoplasm MetastasisCellsTumor Suppressor ProteinsTamoxifenErbb2 GeneCancer CellRegulationResistanceMalignant Breast NeoplasmBreast Cancer CellMigrationPaclitaxelChemotherapyDoseHormone TherapyPolyethylene GlycolsPre-ClinicalFemaleDesignIn Vivo
Grant awards (17)
ERK-Signaling in Microenvironment of Pancreatic cancer: Development of NovelTherapeutic Hypoxia-Responsive Nano-encapsulated ERK inhibitor$0
I01 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
ERK-Signaling in Microenvironment of Pancreatic cancer: Development of NovelTherapeutic Hypoxia-Responsive Nano-encapsulated ERK inhibitor$0
I01 · FY2024 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
CCN5 Therapy for Triple Negative Breast Cancer$0
I01 · FY2023 · VA · contact PI
CCN5 Therapy for Triple Negative Breast Cancer$0
I01 · FY2022 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
CCN5 Therapy for Triple Negative Breast Cancer$0
I01 · FY2021 · VA · contact PI
CCN5 Therapy for Triple Negative Breast Cancer$0
I01 · FY2020 · VA · contact PI
The Role of CCN5 in Progression of Breast Cancer$0
I01 · FY2016 · VA · contact PI
The Role of CCN5 in Progression of Breast Cancer$0
I01 · FY2015 · VA · contact PI
The Role of CCN5 in Progression of Breast Cancer$0
I01 · FY2014 · VA · contact PI
The Role of CCN5 in Progression of Breast Cancer$0
I01 · FY2013 · VA · contact PI
ROLE OF VEGF AND NRP 1 IN ESTROGEN INDUCED ANGIOGENESIS$170,100
R01 · FY2002 · CA
ROLE OF VEGF AND NRP 1 IN ESTROGEN INDUCED ANGIOGENESIS$170,100
R01 · FY2001 · CA
ROLE OF VEGF AND NRP 1 IN ESTROGEN INDUCED ANGIOGENESIS$170,100
R01 · FY2000 · CA